Literature DB >> 32402562

Longitudinal changes of left and right cardiac structure and function in patients with end-stage renal disease on replacement therapy.

Luca Arcari1, Giuseppino Massimo Ciavarella2, Silvia Altieri3, Luca Rosario Limite2, Domitilla Russo2, Michelangelo Luciani4, Luciano De Biase5, Paolo Mené3, Massimo Volpe6.   

Abstract

BACKGROUND: Few data are available regarding longitudinal changes of cardiac structure and function in end-stage chronic kidney disease (CKD). Aim of the present study is to describe serial echocardiographic findings in a cohort of dialyzed CKD patients.
METHODS: In this retrospective longitudinal study, we included n = 120 dialyzed CKD patients who underwent at least 2 echocardiograms either 1, 2 or 3 years apart. After baseline echocardiogram, n = 112 had a further examination at year 1, n = 76 at year 2 and n = 45 at year 3. Echocardiographic examination included Tissue Doppler Imaging of both left (LV) and right (RV) ventricle.
RESULTS: LV geometry and LV mass index did not significantly change over time. RV progressively dilated (mean change +1.3 mm, +1.1 mm and +3.1 mm at year 1, 2 and 3 respectively, p = 0.002, adjusted p = 0.003). Tissue Doppler parameters showed significant changes with regard to both LV (mean change of E/E' +0.7, +1.3, +1.7 at year 1, 2 and 3 respectively p<0.001, adjusted p = 0.079) and RV (mean change of S wave (cm/sec) -1, -1.7, -2 at year 1, 2 and 3 respectively, p <0.001, adjusted p = 0.041). Decrease of RV S wave negatively correlated with E/E' changes (r=-0.303, p = 0.002; r=-0.246, p = 0.049; r=-0.265, p = 0.089; at year 1, 2 and 3 respectively). LV ejection fraction (LVEF) progressively declined (p = 0.034, adjusted p = 0.140), albeit being significant lower against baseline only at year 3 (mean change -4.3%, p<0.05).
CONCLUSIONS: In dialyzed CKD patients we observed parallel worsening of LV diastolic and RV systolic function accompanied by RV dilation. LVEF decreased less sharply.
Copyright © 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Dialysis; Diastolic dysfunction; Right ventricle; Tissue Doppler echocardiography

Mesh:

Year:  2020        PMID: 32402562     DOI: 10.1016/j.ejim.2020.04.051

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  5 in total

Review 1.  Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.

Authors:  Yinghui Wang; Lu Gao
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

2.  Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach.

Authors:  Lorenzo Falsetti; Vincenzo Zaccone; Giovanna Viticchi; Agnese Fioranelli; Ilaria Diblasi; Emanuele Guerrieri; Consuelo Ferrini; Mattia Scarponi; Luca Giuliani; Caterina Scalpelli; Marianna Martino; Adolfo Pansoni; Marinella Luccarini; Maurizio Burattini; Gianluca Moroncini; Nicola Tarquinio
Journal:  Diagnostics (Basel)       Date:  2022-02-13

3.  Prognostic Impact of the HFA-PEFF Score in Patients with Acute Myocardial Infarction and an Intermediate to High HFA-PEFF Score.

Authors:  Kwan Yong Lee; Byung-Hee Hwang; Chan Jun Kim; Young Kyoung Sa; Young Choi; Jin-Jin Kim; Eun-Ho Choo; Sungmin Lim; Ik Jun Choi; Mahn-Won Park; Gyu Chul Oh; In-Ho Yang; Ki Dong Yoo; Wook Sung Chung; Kiyuk Chang
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

4.  Cardiac biomarkers in chronic kidney disease are independently associated with myocardial edema and diffuse fibrosis by cardiovascular magnetic resonance.

Authors:  Luca Arcari; Juergen Engel; Tilo Freiwald; Hui Zhou; Hafisyatul Zainal; Monika Gawor; Stefan Buettner; Helmut Geiger; Ingeborg Hauser; Eike Nagel; Valentina O Puntmann
Journal:  J Cardiovasc Magn Reson       Date:  2021-06-07       Impact factor: 5.364

Review 5.  T1 and T2 Mapping in Uremic Cardiomyopathy: An Update.

Authors:  Luca Arcari; Giovanni Camastra; Federica Ciolina; Massimiliano Danti; Luca Cacciotti
Journal:  Card Fail Rev       Date:  2022-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.